InvestorsHub Logo
Followers 0
Posts 14
Boards Moderated 0
Alias Born 12/19/2016

Re: None

Wednesday, 12/21/2016 11:07:04 AM

Wednesday, December 21, 2016 11:07:04 AM

Post# of 639
Phase 3 trial of Medidur™ in Posterior Segment Uveitis Meets Enrollment Target
http://psdv.client.shareholder.com/releasedetail.cfm?ReleaseID=991962
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EYPT News